胚胎著床之窗:子宮內膜藏秘密通道:鈉離子通道,胚胎著床先進秘密通道,子宮輕搔癢有助著床

2012.12.19

 

胚胎著床之窗:子宮內膜藏秘密通道:鈉離子通道,胚胎著床先進秘密通道,子宮輕搔癢有助著床

 

 

怪!子宮刮傷,可增加試管嬰兒增加率 Sti EM

    最近我查了三份報告來自於加拿大和以色列,意外發現有一種「新的試管嬰兒增加成功率的方法」,叫做子宮內膜刺激素,它的做法是在做試管嬰兒前一到三個月,可以在子宮的前壁跟後壁個輕刮三條線,小小的出血,我們都知道我們人體的組織在受傷之後復原,會有發炎反應、生長激素、細胞動力素大量分泌,而這些生長激素極細胞動力素是大大有助於胚胎著床的,使用這種子宮內膜的刺激素意外增加了非常高的懷孕率,尤其是試管嬰兒胚胎著床,如果妳以前多次失敗,可以用「子宮內膜刺激素」大大增加成功率!

輕刮子宮內膜  提高試管嬰兒 著床率

子宮內膜刮:

 

 

 

 

 

 

 

中文大學最近破解了人類胚胎成孕之謎。中大發現了上皮細胞的鈉離子通道在胚胎著床(或胚胎植入子宮)過程中不可或缺的作用,開展診斷不孕症的新路向。中文的研究剛於國際醫學界其中一份最具影響力的期刊《自然醫學》上刊登。 採訪:靜態組

有關研究由中大李嘉誠生理學講座教授兼上皮細胞生物學研究中心主任陳小章教授領導的研究團隊負責。陳小章表示,研究團隊的發現,不僅揭開了長期以來關於胚胎植入子宮的啟動過程的謎團,並闡述了流產或試管嬰兒成功率低下的一個重要原因,同時,研判亦為診斷不孕及進行避孕提供了新的方法。

先決條件可創造:子宮內膜〝輕〞刮一刮(內膜刺激術)
胚胎附著子宮內膜後,引起滋養層細胞分化的「蛻膜化」過程是成功懷孕的先決條件。但胚胎最初只接觸到子宮內膜表層的上皮細胞,而來自胚胎的物理或化學的訊號,是如何傳遞到子宮內膜下面的滋養層細胞,從而引發 「蛻膜化」反應呢?這個問題一直找不到答案。 
陳教授說:「我們發現表達在子宮內膜上皮細胞上的鈉離子通道,可以被胚胎釋放的蛋白質激活,讓上皮細胞釋放出可以誘導滋養層細胞『蛻膜化』的重要份子前列腺素E2PGE2)。」她補充說:「我們亦發現曾接受輔助生殖技術卻未能成孕的婦女,其子宮內膜的上皮細胞鈉離子通道的表達水平,明顯比通過此技術成功受孕的婦女要低。」 
上皮細胞生物學研究中心一直引領人類生育相關的上皮細胞生物學研究,曾多次發表有關控制生育的份子機制和不育成因的重大發現。這些貢獻為她帶來多個重要獎項榮譽,包括兩次國家自然科學獎(1997年及2008年)和「長江學者成就獎」(2007年)。

 

子宮內膜刮:


Molecular determinant of implantation success uncovered
By Eleanor McDermid
26 June 2012
Nat Med 2012; Advance online publication

MedWire News: A signaling sequence initiated by the embryo and hinging on the epithelial Na+ channel (ENaC) leads to successful implantation, researchers report in Nature Medicine.

The team's results come mainly from experiments in cultured cells. But Hsiao Chang Chan (The Chinese University of Hong Kong) and colleagues found that pharmacologic inhibition of ENaC caused a dose-dependent reduction in implantation rates in mice after mating, and they also found supporting evidence in women undergoing IVF.

ENaC levels in endometrial samples obtained prior to embryo transfer were significantly lower in 16 women with successful pregnancies than in 16 with failed pregnancies. Age, ovarian hormonal profiles, endometrial thickness, and oocyte quality were similar between the groups.

"As ENaC expression is subject to regulation by ovarian hormones, its normal expression pattern may be altered during IVF with ovarian overstimulation, which may contribute to the low pregnancy rate achieved through IVF," says the team.

"Thus, defects in ENaC, either in its expression or its function, may be one of the underlying mechanisms for spontaneous miscarriage and implantation failure during IVF."

Further analysis of separate groups of 16 women with successful and 17 with failed pregnancies showed that the latter group had significantly reduced expression of the ENaCα and ENaCaγ subunits, but not the ENaβ subunit.

The ENaCγ subunit contains a protease activation site. The researchers' laboratory experiments show that the chain of events leading to stromal decidualization (a prerequisite for embryo transplantation) begins with the release of a serine protease, trypsin, from the embryo.

Trypsin release caused ENaC activation and Na+ influx in endometrial epithelial cells, leading to membrane depolarization. Depolarization triggered Ca2+ mobilization, upregulation of cyclooxygenase-2, and release of prostaglandin E2 (PGE2), which is essential for embryo implantation.

"The ability of ENaC to regulate PGE2 production and release, as we showed here, may have far-reaching implications beyond embryo implantation or reproduction, as ENaC is widely distributed throughout the body and PGE2 is a versatile regulator of many physiological functions and pathological processes," say the researchers.

PGE2 release from the epithelial cells culminated in the decidualization of stromal cells, which underwent marked morphologic changes from elongated into polygonal and multinuclear cells.

The researchers comment: "Given that ENaC is mechanosensitive, the presently demonstrated involvement of ENaC in decidualization also provides an explanation for the long-observed induction of decidualization by mechanical stimuli in animal models and improved implantation rate in women undergoing IVF after endometrial scratch."

MedWire (www.medwire-news.md) is an independent clinical news service provided by Springer Healthcare Limited. © Springer Healthcare Ltd; 2012